CAP 3

Catalog No.: A50565
Antibacterial Agents
CAP 3 is a cholic acid-peptide conjugate that acts as an effective antibacterial agent targeting Gram-negative bacteria. It demonstrates potent antibacterial activity with minimum inhibitory concentration (MIC99) values of 8 μM, 16 μM, and 16 μM against E. coli, Klebsiella pneumoniae, and Acinetobacter baumannii, respectively. CAP 3 functions by disrupting the structural integrity of bacterial lipopolysaccharide (LPS) outer membranes, leading to rapid bacterial cell death. Additionally, it inhibits biofilm formation and shows efficacy against drug-resistant strains, making it valuable for addressing persistent bacterial infections in research settings.
Grouped product items
Size Price Stock Qty
1mg
$195.00
In stock
5mg
$605.00
In stock
10mg
$990.00
In stock
Bulk Size
Bulk Discount
Free Delivery on orders over $500
Research use only. We do not sell to patients.

Loading distributor info...

Adooq Products cited in reputable paper
Science VOLUME 380, ISSUE 6663 (2023)
Science VOLUME 369, ISSUE 6510 (2020)
Science VOLUME 356, ISSUE 6336 (2017)
Cell Vol. 185 Issue 23 p4428-4447.e28
Cell Vol 177, Issue 7, p1933-1947.e25
Cell Vol 156, Issue 5, p857-1114
Nature Volume 622 Issue 7982 (2023)
Nature volume 620, pages890-897 (2023)
Nature volume 610, pages540-546 (2022)
Nature volume 588, pages83-88 (2020)
Nature volume 574, pages268-272 (2019)
Nature volume 573, pages539-545 (2019)
Nature volume 567, pages118-122 (2019)
Nature volume 551, pages639-643 (2017)
Nature volume 551, pages247-250 (2017)
Nature volume 548, pages356-360 (2017)
Nature volume 545, pages187-192 (2017)
Biological Activity
DescriptionCAP 3 is a cholic acid-peptide conjugate that acts as an effective antibacterial agent targeting Gram-negative bacteria. It demonstrates potent antibacterial activity with minimum inhibitory concentration (MIC99) values of 8 μM, 16 μM, and 16 μM against E. coli, Klebsiella pneumoniae, and Acinetobacter baumannii, respectively. CAP 3 functions by disrupting the structural integrity of bacterial lipopolysaccharide (LPS) outer membranes, leading to rapid bacterial cell death. Additionally, it inhibits biofilm formation and shows efficacy against drug-resistant strains, making it valuable for addressing persistent bacterial infections in research settings.
Product Information
Catalog NumA50565
FormulaC52H82N6O11
Molecular Weight967.24
CAS Number2292123-03-4
SMILESCC(C)[C@H](N)C(NCC(O[C@H]1[C@]2([H])[C@@](C[C@@H]([C@]3([C@@]2([H])CC[C@]3([H])[C@H](C)CCC(OCC4=CC=CC=C4)=O)C)OC(CNC([C@@H](N)C(C)C)=O)=O)([H])[C@@]5([C@](C[C@@H](CC5)OC(CNC([C@@H](N)C(C)C)=O)=O)([H])C1)C)=O)=O
Useful Calculator

This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass

    Concentration

    Volume

    Molecular Weight

Please check COA/MSDS for correct molecular weight.

Calculate the dilution required to prepare a stock solution.
This equation is commonly abbreviated as: C1V1 = C2V2

  • C1

    V1

    C2

    V2